Super Bowl ad for Hims & Hers' weight loss drug sparks backlash
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, which both contain the active ingredient semaglutide and are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes and obesity, respectively.
Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...
Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
Drugs like Ozempic and Wegovy — known as glucagon-like peptide-1 receptor agonists, or GLP-1s — have made headlines and surged in popularity for their unique ability to help patients lose weight by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback